A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

NCT04936529 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

286

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

DIETARY_SUPPLEMENT: β-glucan
DRUG: GM-CSF
BIOLOGICAL: OPT-821

Sponsor

Memorial Sloan Kettering Cancer Center